Rule 1: If a molecule has either a sulfonamide group (-SO2NH-) or a nitro group (-NO2), it could potentially have side effects related to endocrine disorders.
Rule 2: Presence of aromatic rings and halogen atoms in a molecule could also pose a risk of causing adverse effects, as they can interact with biological macromolecules and lead to changes in function.
Rule 3: If the molecule has a long chain or complex structure, it tends to increase the likelihood of unwanted interactions within the body and therefore could potentially cause side effects related to endocrine disorders.
Rule 4: Molecules with functional groups like carbonyl or carboxyl could have potential side effects on endocrine disorders as they could be metabolized into active compounds which might interfere with hormone production and regulation.
Rule 5: Molecules containing a benzene ring connected to a carbonyl group via a single bond may have fewer side effects related to endocrine disorders.
Rule 6: Presence of a guanidine group in a molecule could potentially have side effects related to endocrine disorders.
Rule 7: If a molecule contains a halogen atom, especially chlorine or bromine, it may increase the probabilities of causing adverse effects due to their ability to disrupt protein-ligand interactions within the body.
Rule 8: Molecules with cyano group (-CN) and a pyridine or pyrimidine ring could exhibit endocrine disrupting activities due to their ability to bind to receptors in the body, potentially interfering with normal hormonal signaling pathways.
Rule 9: The presence of certain functional groups, such as a benzene or sulfonyl group, in a molecule increases its potential to have side effects related to endocrine disorders.
Rule 10: Molecules with a chlorine atom bonded to a carbon atom adjacent to a carbonyl group (-C=O), could potentially cause endocrine disorders.
Rule 1: A molecule may have potential for causing adverse effects on the endocrine system if it contains a functional group such as a carbonyl or carboxyl. 

Rule 2: A molecule that contains nitrogen atoms bonded to carbon atoms may also cause potential adverse effects on the endocrine system.

Rule 3: A molecule's likelihood of causing adverse effects on the endocrine system may increase if it contains halogen atoms such as chlorine or fluorine.

Rule 4: The potential of a compound to cause endocrine disorders may indicate by the presence of a sulfonamide group. These groups are known to interfere with hormone production.

Rule 5: A compound containing a nitro group attached to an aromatic ring may also have potential to cause endocrine disorders due to its ability to disrupt hormonal signaling pathways.

Rule 6: In comparison to those without these, compounds containing conjugated double bonds and carbonyl groups may be more likely to cause adverse effects on the endocrine system. 

Rule 7: If the molecule contains a sulfonamide group and a benzene ring, it might have endocrine-disrupting side effects. 

Rule 8: Potential endocrine-disrupting side effects may occur if a molecule contains a chlorine atom and a pyrimidine ring.

Rule 9: A molecule containing a carbonyl group and a naphthalene ring might have side effects related to endocrine disorders.

Rule 10: A molecule with a carbonyl group in its structure may indicate potential endocrine-disrupting side effects.

Rule 11: The potential for endocrine-disrupting side effects may decrease if the molecule contains a nitro group or a nitrile group in its structure.

Rule 12: A molecule containing a benzene ring or a naphthalene ring in its structure may indicate potential side effects related to endocrine disorders.

Rule 13: The potential for endocrine-disrupting side effects may decrease if the molecule contains a negatively charged oxygen atom bonded to one carbon atom and a positively charged calcium ion bonded to another carbon atom.

Rule 14: The presence of a nitro group and a conjugated system of double bonds in a molecule may indicate toxicity due to the ability of the molecule to form free radicals.

Rule 15: The presence of a nitro group in a molecule may indicate potential endocrine-disrupting side effects.

Rule 16: Potential endocrine-disrupting side effects may occur if the molecule contains a carbonyl group connected to a carbon atom that also has two other bonds, one of which is a double bond or a triple bond.

Rule 17: A molecule containing a long chain of carbon atoms with multiple functional groups, including alcohols, aldehydes, and carboxylic acids, may have endocrine-disrupting side effects.

Rule 18: A molecule with a chloride ion or a zinc atom in its structure likely has endocrine-disrupting side effects. 

Rule 19: A molecule with a nitrogen atom bonded to two carbon atoms may not have endocrine-disrupting side effects.

Rule 20: Molecules containing a benzene ring or a naphthalene ring may have endocrine-disrupting side effects but need additional factors considered in prediction.

Rule 21: Side effects related to endocrine disorders may occur if the molecule contains a sulfonyl group or a carbonyl group in its structure.

Rule 22: Molecules containing a benzene ring or a naphthalene ring in its structure may not have potential endocrine-disrupting side effects.

Rule 23: If the molecule contains a nitrogen atom bonded to at least two carbon atoms, it may have endocrine-disrupting side effects.

Rule 24: A molecule containing a bromine atom likely has endocrine-disrupting side effects.

Rule 25: A molecule containing a fluorine atom and a benzene ring may not have side effects related to endocrine disorders.

Rule 26: If a molecule contains a carbonate group or a phosphate group, it may have an increased likelihood of side effects related to endocrine disorders.

Rule 27: The presence of a benzene ring connected to a carbonyl group through a single bond may indicate increased likelihood of side effects related to endocrine disorders.

Rule 28: The presence of a nitro group attached to an adjacent carbon atom to a double bond may increase the likelihood of side effects related to endocrine disorders.

Rule 29: A molecule containing a nitrogen-containing heterocycle, such as a pyrimidine or pyrazine ring, may have an increased likelihood of side effects related to endocrine disorders.

Rule 30: If a molecule contains a sulfonyl group or a phosphate group, then it may have potential side effects related to endocrine disorders.

Rule 31: A molecule with a nitrogen atom bonded to four other atoms, including two carbon atoms and one oxygen atom, may have side effects related to endocrine disorders. 

Rule 32: The presence of fluorine atoms in a molecule's structure may increase its potential for endocrine disruption. 

Rule 33: If a molecule has a benzene ring attached to a sulfonyl group or a similar group, it may have endocrine-disrupting activity.

Rule 34: If the molecule contains a conjugated system of double bonds between two aromatic rings, it may also have endocrine-disrupting activity. 

Rule 35: The presence of a nitro group attached to an aromatic ring may indicate the potential for endocrine-disrupting activity. 

Rule 36: The presence of a sulfonyl group or a nitro group in a molecule may increase its potential for causing side effects on human health due to its ability to bind to proteins and disrupt their normal function. 

Rule 37: The size and shape of a molecule may also play a role in determining its ability to interact with biological systems and potentially cause adverse effects.

Rule 38: The stereochemistry of a molecule may also affect its activity and potential for causing adverse effects.

Rule 39: If a molecule contains a cyano group (-CN) attached to an aromatic ring, then it may have side effects related to endocrine disorders.

Rule 40: A compound containing a phosphonic acid group or a carboxylic acid group bonded to an aliphatic chain may not have any significant side effects related to endocrine disorders.
